期刊文献+

基于血小板及其膜的仿生递药系统研究进展 被引量:2

Advances in biomimetic drug delivery systems based on platelet and platelet membrane
下载PDF
导出
摘要 血小板是人体血液中重要的固有成分,在机体各类生理反应中发挥重要作用。近年来,基于血小板及其膜的仿生新型药物传递系统备受关注。与传统药物载体相比,血小板及其膜仿生递药系统具有生物相容性好、血液循环时间长和体内靶向性强等优势。本文介绍了基于血小板及其膜仿生递药系统的特点、种类、载药方式及应用,以期促进血小板及其膜仿生载体在药物递送领域的研究与应用。 Platelet is an important component of human blood,which plays a key role in the physiological and pathological processes.Recently,novel drug delivery system based on platelet and platelet membrane bionics attracted much attention.Compared to the traditional drug carriers,platelet and platelet membrane-based biomimetic drug delivery system has great performances in biocompatibility,longer circulation and stronger ability of targeting.This review presented the features,classifications,drug-loading and applications of platelet and platelet membrane-based biomimetic drug delivery systems,promoting their development and application in the future.
作者 徐剑培 徐群为 王晓琪 辛洪亮 XU Jianpei;XU Qunwei;WANG Xiaoqi;XIN Hongliang(Pharmacy School of Nanjing Medical University,Nanjing 211166,China)
出处 《中国药科大学学报》 CAS CSCD 北大核心 2018年第6期653-659,共7页 Journal of China Pharmaceutical University
基金 国家自然科学基金资助项目(No.31671018)~~
关键词 血小板 血小板膜 药物载体 生物仿生 纳米 递药系统 blood platelets platelet membrane drug carriers biomimetics nano drug delivery system
  • 相关文献

参考文献2

二级参考文献65

  • 1Zhang L, Song J, Cavigiolio G, et al. Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy [ J ]. J Lipid Res, 2011,52 ( 1 ) : 175 - 184.
  • 2Sabnis N, Lacko AG. Drug delivery via lipoprotein-based carri- ers : answering the challenges in systemic therapeutics [ J ]. Thera- peutic Deliv ,2012,3 (5) :599 - 608.
  • 3Zhang Z, Chen J, Ding L, et al. HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting [ J ]. Small, 2010,6 (3) :430 -437.
  • 4Davis ME, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer [ J ]. Nat Rev Drug Discov 2008,7 (9) :771 -782.
  • 5Dieekmann M, Dietrich MF, Herz J. Lipoprotein receptors--an evolutionarily ancient multifunctional receptor family [ J ]. J Biol Chem,2010,391 ( 11 ) : 1341 - 1363.
  • 6Danilo C, Gutierrez-Pajares JL, Mainieri MA, et aL Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development [ J ]. Breast Cancer Res, 2013,15 ( 5 ) : R87.
  • 7Twiddy AL, Cox ME, Wasan KM. Knockdown of scavenger receptor class B type I reduces prostate specific antigen secretion and viability of prostate cancer cells [ J ]. Prostate, 2012,72 ( 9 ) : 955 - 965.
  • 8Narasimhan K, Pillay S, Bin Ahmad NR, et al. Identification of a polyoxometalate inhibitor of the DNA binding activity of Sox2 [ J] .ACS Chem B/o/,2011,6(6) :573 -581.
  • 9Guo D, Reinitz F, Youssef M, et al. An LXR agunist promotes glioblastoma cell death through inhibition of an EGFR/AKT/ SREBP-1/LDLR-dependent pathway [ J ]. Cancer Discov, 2011,1 (5) :442 -456.
  • 10Leon CG, Locke JA, Adomat HH, et al. Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model [ J ]. Prostate,2010,70 (4) :390 - 400.

共引文献8

同被引文献17

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部